Satlin A

References (3)

Title : ADCOMS: a composite clinical outcome for prodromal Alzheimer's disease trials - Wang_2016_J.Neurol.Neurosurg.Psychiatry_87_993
Author(s) : Wang J , Logovinsky V , Hendrix SB , Stanworth SH , Perdomo C , Xu L , Dhadda S , Do I , Rabe M , Luthman J , Cummings J , Satlin A
Ref : Journal of Neurology Neurosurg Psychiatry , 87 :993 , 2016
Abstract : Wang_2016_J.Neurol.Neurosurg.Psychiatry_87_993
ESTHER : Wang_2016_J.Neurol.Neurosurg.Psychiatry_87_993
PubMedSearch : Wang_2016_J.Neurol.Neurosurg.Psychiatry_87_993
PubMedID: 27010616

Title : Rivastigmine in Alzheimer disease: efficacy over two years - Grossberg_2004_Am.J.Geriatr.Psychiatry_12_420
Author(s) : Grossberg G , Irwin P , Satlin A , Mesenbrink P , Spiegel R
Ref : American Journal of Geriatry & Psychiatry , 12 :420 , 2004
Abstract : Grossberg_2004_Am.J.Geriatr.Psychiatry_12_420
ESTHER : Grossberg_2004_Am.J.Geriatr.Psychiatry_12_420
PubMedSearch : Grossberg_2004_Am.J.Geriatr.Psychiatry_12_420
PubMedID: 15249280

Title : Effects of xanomeline, a selective muscarinic receptor agonist, on cognitive function and behavioral symptoms in Alzheimer disease - Bodick_1997_Arch.Neurol_54_465
Author(s) : Bodick NC , Offen WW , Levey AI , Cutler NR , Gauthier SG , Satlin A , Shannon HE , Tollefson GD , Rasmussen K , Bymaster FP , Hurley DJ , Potter WZ , Paul SM
Ref : Archives of Neurology , 54 :465 , 1997
Abstract : Bodick_1997_Arch.Neurol_54_465
ESTHER : Bodick_1997_Arch.Neurol_54_465
PubMedSearch : Bodick_1997_Arch.Neurol_54_465
PubMedID: 9109749